Note 3 - Supplemental Balance Sheet and Cash Flow Information (Tables)
|
12 Months Ended |
Jun. 30, 2021 |
|---|
| Notes Tables |
|
| Schedule of Inventory, Current [Table Text Block] |
| |
|
June 30, |
|
| |
|
2021 |
|
|
2020 |
|
| |
|
|
|
|
|
|
|
|
| Raw materials |
|
$ |
55,096 |
|
|
$ |
51,530 |
|
| Finished goods(1) |
|
|
67,108 |
|
|
|
56,268 |
|
| Inventories, net |
|
$ |
122,204 |
|
|
$ |
107,798 |
|
|
| Property, Plant and Equipment [Table Text Block] |
| |
|
June 30, |
|
| |
|
2021 |
|
|
2020 |
|
| Cost: |
|
|
|
|
|
|
|
|
| Land |
|
$ |
8,612 |
|
|
$ |
8,516 |
|
| Buildings and improvements |
|
|
190,661 |
|
|
|
184,430 |
|
| Machinery, equipment and other |
|
|
198,483 |
|
|
|
153,704 |
|
| Property and equipment |
|
|
397,756 |
|
|
|
346,650 |
|
| Accumulated depreciation and amortization |
|
|
(189,849 |
) |
|
|
(169,821 |
) |
| Property and equipment, net |
|
$ |
207,907 |
|
|
$ |
176,829 |
|
|
| Schedule of Intangible Assets and Goodwill [Table Text Block] |
| |
|
|
|
|
|
|
|
June 30, |
|
| |
|
Useful Life (years) |
|
|
2021 |
|
|
2020 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Developed technology |
|
|
9 |
- |
15 |
|
|
$ |
552,160 |
|
|
$ |
434,653 |
|
| Trade names |
|
|
2 |
- |
20 |
|
|
|
147,640 |
|
|
|
146,713 |
|
| Customer relationships |
|
|
7 |
- |
16 |
|
|
|
232,493 |
|
|
|
211,750 |
|
| Patents |
|
|
|
10 |
|
|
|
|
2,926 |
|
|
|
2,475 |
|
| Other intangibles(1)
|
|
|
5 |
- |
15 |
|
|
|
6,316 |
|
|
|
- |
|
| Definite-lived intangible assets |
|
|
|
|
|
|
|
|
941,535 |
|
|
|
795,591 |
|
| Accumulated amortization |
|
|
|
|
|
|
|
|
(348,267 |
) |
|
|
(279,046 |
) |
| Definite-lived intangibles assets, net |
|
|
|
|
|
|
|
|
593,268 |
|
|
|
516,545 |
|
| In process research and development |
|
|
|
|
|
|
|
|
22,700 |
|
|
|
- |
|
| Total intangible assets, net |
|
|
|
|
|
|
|
$ |
615,968 |
|
|
$ |
516,545 |
|
|
| Schedule of Finite-Lived Intangible Assets [Table Text Block] |
| |
|
|
June 30, |
|
| |
|
|
2021 |
|
|
2020 |
|
| |
|
|
|
|
|
|
|
|
|
| Beginning balance |
|
|
$ |
516,545 |
|
|
$ |
579,429 |
|
| Acquisitions (Note 4) |
|
|
|
153,311 |
|
|
|
- |
|
| Other additions |
|
|
|
5,912 |
|
|
|
311 |
|
| Amortization expense |
|
|
|
(64,940 |
) |
|
|
(61,095 |
) |
| Currency translation |
|
|
|
5,140 |
|
|
|
(2,100 |
) |
| Ending balance |
|
|
$ |
615,968 |
|
|
$ |
516,545 |
|
|
| Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] |
| 2022 |
|
$ |
74,482 |
|
| 2023 |
|
|
72,649 |
|
| 2024 |
|
|
69,780 |
|
| 2025 |
|
|
66,523 |
|
| 2026 |
|
|
62,739 |
|
| Thereafter |
|
|
247,095 |
|
| Total |
|
$ |
593,268 |
|
|
| Schedule of Goodwill [Table Text Block] |
| |
|
Protein Sciences |
|
|
Diagnostics & Genomics |
|
|
Total |
|
| June 30, 2019 |
|
$ |
377,407 |
|
|
$ |
355,260 |
|
|
$ |
732,667 |
|
| Acquisitions (Note 4) |
|
|
(326 |
) |
|
|
- |
|
|
|
(326 |
) |
| Currency Translation |
|
|
(4,000 |
) |
|
|
(31 |
) |
|
|
(4,031 |
) |
| June 30, 2020 |
|
$ |
373,081 |
|
|
$ |
355,229 |
|
|
$ |
728,310 |
|
| Acquisitions (Note 4) |
|
|
7,848 |
|
|
|
94,970 |
|
|
|
102,818 |
|
| Currency translation |
|
|
11,788 |
|
|
|
151 |
|
|
|
11,939 |
|
| June 30, 2021 |
|
$ |
392,717 |
|
|
$ |
450,350 |
|
|
$ |
843,067 |
|
|
| Schedule of Cash Flow, Supplemental Disclosures [Table Text Block] |
| |
|
Year Ended June 30, |
|
| |
|
2021 |
|
|
2020 |
|
|
2019 |
|
| Income taxes paid |
|
$ |
20,952 |
|
|
$ |
41,992 |
|
|
$ |
36,814 |
|
| Interest paid |
|
|
13,576 |
|
|
|
18,615 |
|
|
|
21,497 |
|
| Non-cash activities: |
|
|
|
|
|
|
|
|
|
|
|
|
| Acquisition-related liabilities(1) |
|
|
23,600 |
|
|
|
(2,105 |
) |
|
|
12,600 |
|
| Other intangibles(2)
|
|
|
4,000 |
|
|
|
- |
|
|
|
- |
|
|